Stifel Nicolaus analyst Rick Wise has maintained their bullish stance on ATRC stock, giving a Buy rating yesterday.Stay Ahead of the ...

Check the time stamp on this data. Updated AI-Generated Signals for Atricure Inc. (ATRC) available here: ATRC. Type a few ...

In a report released today, Michael Matson from Needham reiterated a Buy rating on Atricure (ATRC – Research Report), with a price target of ...

Check the time stamp on this data. Updated AI-Generated Signals for Atricure Inc. (ATRC) available here: ATRC.

AtriCure reported preliminary Q4 revenue results that beat the Wall Street consensus, with expectations for sales to grow ...

AtriCure, Inc. (NASDAQ: ATRC) recently announced the receipt of an expanded indication for the AtriClip in CE-marked countries in Europe. The product is now indicated for use in patients at ...

AtriCure, Inc. (ATRC) has launched the cryoSPHERE MAX cryoablation ... generated positive sentiment among investors, driving ...

MASON, Ohio, December 23, 2024--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management ...

Several analysts have weighed in on ATRC shares. UBS Group boosted their price target on shares of AtriCure from $35.00 to $40.00 and gave the stock a “buy” rating in a research note on ...

Shares of ATRC opened at $34.72 on Tuesday. The firm’s 50 day moving average is $30.08 and its 200-day moving average is $25.43. The stock has a market capitalization of $1.69 billion ...